Chemotherapy-induced anemia market forecast to hit $4.13 billion by 2030
The chemotherapy-induced anemia market is projected to grow from $2.81 billion in 2025 to $4.13 billion by 2030, driven by more intensive cancer treatment, higher anemia rates and wider use of supportive care. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.
Why it matters: - Chemotherapy-induced anemia is a common side effect of cancer treatment and can worsen fatigue, weakness and quality of life. - Growth in supportive care spending reflects the rising need to help patients stay on therapy and avoid interruptions tied to anemia. - The market is expanding as oncology care becomes more intensive and more personalized.
What happened: - The Business Research Company released a 2026 report on the chemotherapy-induced anemia market. - The market was valued at $2.81 billion in 2025. - The market is projected to reach $3.03 billion in 2026, implying 7.7% annual growth. - The market is forecast to climb to $4.13 billion by 2030, at an 8.1% CAGR. - The report is available with a free sample. - The full report is also available online.
The details: - Rising use of intensive chemotherapy treatments is a key growth driver. - More cases of treatment-related anemia are expanding demand for management options. - A broader network of oncology treatment centers is supporting market growth. - Better access to blood transfusion services is adding to demand. - Supportive cancer therapies are becoming more widely used. - Long-acting anemia medications are expected to gain demand over the forecast period. - Efforts to reduce reliance on transfusions are shaping treatment choices. - Personalized oncology care is pushing more tailored anemia management. - Home-based treatment approaches are gaining traction. - Advances in anemia management drugs are supporting growth. - Erythropoiesis-stimulating agents remain a major treatment approach. - Early intervention strategies are emerging as a notable trend. - Outpatient treatment settings are becoming more common. - Patient quality of life is a stronger focus across the market.
Between the lines: - The market is growing because anemia management is becoming part of broader cancer-care delivery, not just a separate add-on. - The shift toward outpatient and home-based care suggests providers are looking for ways to reduce treatment burden and dependency on transfusions. - Cancer incidence trends continue to support demand. Cancer Research UK projected a 3% increase in head and neck cancer cases in the UK between 2023 and 2025, along with a 12% rise in related mortality.
What's next: - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says its 2026 reports add market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics. - The company provided contact details for its sales and marketing teams, including Saumya Sahay, Americas +1 310-496-7795, Asia +44 7882 955267 and +91 8897263534, Europe +44 7882 955267, and marketing@tbrc.info.
The bottom line: - Chemotherapy-induced anemia is moving from a niche supportive-care category to a faster-growing global market, with demand tied closely to the scale and complexity of cancer treatment.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Market Forecast Analysis
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.